Constructive Genomics is a spin out from the laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology in Cambridge.
Our platform allow us to fundamentally reprogram the genetic code, and make molecules that nature could not make before. We will use our technologies to biosynthesize new classes of enzymes, pharmaceuticals and biomaterials.
If you would like to join our team, get in touch!
Our platform allow us to fundamentally reprogram the genetic code, and make molecules that nature could not make before. We will use our technologies to biosynthesize new classes of enzymes, pharmaceuticals and biomaterials.
If you would like to join our team, get in touch!
Location: United Kingdom, England, Little Chesterford
Employees: 1-10
Total raised: $73M
Investors 6
| Date | Name | Website |
| 27.10.2025 | ND CAPITAL | nd.capital |
| 02.01.2026 | Paladin Ca... | paladincap... |
| 16.08.2022 | Amadeus Ca... | amadeuscap... |
| 06.11.2023 | OMX Ventur... | omx.vc |
| 14.10.2024 | Fine Struc... | finestruct... |
| 18.08.2022 | Ahren Inno... | ahreninnov... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 24.09.2024 | Series A | $58M | - |
| 15.08.2022 | Seed | $15M | Ahren Inno... |
Mentions in press and media 7
| Date | Title | Description |
| 19.11.2025 | RxCelerate and Constructive Bio announce partnership to advance next-generation therapeutics | Combining Constructive Bio’s pioneering programmable biology platform with RxCelerate’s expert drug design and development capabilities to drive innovation in engineered biologics for challenging diseases. Cambridge, UK – 19 November 2025 –... |
| 24.09.2024 | Constructive Bio Raises $58M in Series A Financing | Constructive Bio, a Cambridge, UK-based synthetic genomics company, raised $58M in Series A funding. The round was led by Ahren, OMX Ventures and Paladin Capital Group with participation from Fine Structure Ventures, +ND Capital and Jonatha... |
| 01.09.2022 | LifeArc helps create new MRC spin-out company | Our technology transfer team played a crucial role in the formation of Constructive Bio, a new Medical Research Council (MRC) spin-out company that aims to reprogramme microbes to enable new materials to be produced – such as drugs and biod... |
| 15.08.2022 | Re-engineering biology, Constructive Bio scores $15 million to make new class of enzymes | Cambridge-based biotech startup Constructive Bio has raised $15 million in funding to create technology for producing synthetic genomes and reprogramming the genetic code of living organisms. This, in turn, will allow scientists to write en... |
| 15.08.2022 | Constructive Bio Raises USD15M in Seed Funding | Constructive Bio, a Cambridge, UK-based biotechnology company, raised $15m in seed funding. The round was led by Ahren alongside Amadeus Capital Partners, General Inception and OMX Ventures. The funding will be used to build out the technol... |
| 15.08.2022 | Constructive bio launches with $15m seed investment to re-engineer biology, creating new classes of enzymes, pharmaceuticals and biomaterials | Cambridge, UK - Constructive Bio announces its launch as a new UK-based biotechnology company following the completion of a $15 million seed round and an exclusive license to IP developed by Professor Jason Chin’s Laboratory at the Medical ... |
| - | Constructive Bio | - |